Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
14.22
+0.57 (4.18%)
Aug 12, 2026, 9:40 AM EDT - Market open
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $1.33 billion as of August 12, 2026. Its market cap has increased by 222.79% in one year.
Market Cap
1.33B
Enterprise Value
1.18B
1-Year Change
222.79%
Ranking
Category
Stock Price
$14.22
ChartMarket Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $1.33B, an increase of 185.09%. That is a compound annual growth rate of 13.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.15B | 50.49% |
| Dec 31, 2025 | 762.50M | -7.97% |
| Dec 31, 2024 | 828.50M | 66.40% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
| Jul 20, 2018 | 467.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 1.21B |
| Wave Life Sciences | 1.19B |
| Cullinan Therapeutics | 1.16B |
| Inventiva | 1.16B |
| Corvus Pharmaceuticals | 1.14B |
| EyePoint | 1.13B |
| Apnimed | 1.09B |
| Lexicon Pharmaceuticals | 1.09B |